FreeStyle Libre flash glucose monitoring – [Technology discontinued]

This guidance has been withdrawn because Freestyle Libre 2 was discontinued in August 2025. At the time of withdrawal, no devices for intermittently scanned (‘flash’) continuous glucose monitoring were available in the UK.

HTW has responded to a request to commence a new evidence review to appraise the clinical and cost effectiveness evidence on use of continuous glucose monitoring in people living with diabetes treated with daily basal insulin injections.

We have also produced reports on real-time continuous glucose monitoring.

A new topic exploration report (TER) has been prepared to inform the HTW Assessment Group decision (20.08.26) on whether to accept this onto the HTW work programme and produce a new evidence review and guidance for NHS Wales. Should this topic be accepted onto the HTW work programme, Guidance is anticipated to be available in spring/summer 2027.

HTW has been advised that: The collective clinical opinion of the National Clinical Leads for Diabetes is that ‘…the original guidance recommendations should continue to be followed until replaced by updated recommendations.’ (National Clinical Lead for Diabetes in Wales, National Clinical Lead for Diabetes in Primary Care in Wales, National Clinical Lead Nurse for Diabetes in Wales, Health Board Leads for Diabetes across Wales, National Research Lead for Diabetes in Wales).